Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
- 1 February 1998
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 351 (9100), 399-403
- https://doi.org/10.1016/s0140-6736(97)07358-3
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study GroupPublished by American Medical Association (AMA) ,1996
- The Etiology of Community-Acquired Pneumonia among Hospitalized Patients during a Chlamydia pneumoniae Epidemic in FinlandThe Journal of Infectious Diseases, 1995
- Risk of pneumonia in patients previously treated in hospital for pneumoniaThe Lancet, 1992
- The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide VaccineNew England Journal of Medicine, 1991
- Demonstration of pneumolysin antibodies in circulating immune complexes—a new diagnostic method for pneumococcal pneumoniaSerodiagnosis and Immunotherapy in Infectious Disease, 1990
- Measurement of antibody responses to pneumolysin-A promising method for the presumptive aetiological diagnosis of pneumococcal pneumoniaJournal of Infection, 1989
- Inefficacy of pneumococcal vaccine in a high-risk populationAmerican Journal Of Medicine, 1987
- Pneumococcal Infection and Immunologic Response to Pneumococcal Vaccine in Chronic Obstructive Pulmonary DiseaseChest, 1987
- Efficacy of Pneumococcal Vaccine in High-Risk PatientsNew England Journal of Medicine, 1986
- Resolving the Pneumococcal Vaccine Controversy: Are There Alternatives to Randomized Clinical Trials?Clinical Infectious Diseases, 1984